We present a case of giant cavernous hemangioma of the liver with disseminated intravascular coagulopathy (Kasabach-Merritt syndrome) which was cured by enucleation. The 51 year old woman presented with increased abdominal girth and easy bruisability. Workup elsewhere revealed a massive hepatic hemangioma and she was started on radiation therapy to the lesion and offered an orthotopic liver transplant. After careful preoperative preparation, we felt that resection was possible and she underwent a successful enucleation. The operation and postoperative course were complicated by bleeding but she recovered and remains well in followup after 6 months. All coagulation parameters have returned to normal. Enucleation should be considered the treatment of choice for hepatic hemangiomas, including those presenting with Kasabach-Merritt syndrome. The benefits of enucleation as compared to liver transplantation for these lesions are discussed.
We present a case of giant cavernous hemangioma of the liver with disseminated intravascular coagulopathy (Kasabach-Merritt syndrome) which was cured by enucleation. The 51 year old woman presented with increased abdominal girth and easy bruisability. Workup elsewhere revealed a massive hepatic hemangioma and she was started on radiation therapy to the lesion and offered an orthotopic liver transplant. After careful preoperative preparation, we felt that resection was possible and she underwent a successful enucleation. The operation and postoperative course were complicated by bleeding but she recovered and remains well in followup after 6 [4] . These may present with symptoms varying from slight discomfort in the upper abdomen to spontaneous rupture of the hemangioma. More rarely, as in the current case, hemangiomas present with consumption coagulopathy [5] .
The primary pathophysiologic event of the Kasabach- [6] .
Non surgical treatment of cavernous hemangiomas of the liver include radiation therapy and embolization and have had mixed success.
Reports utilizing radiation therapy have described a partial or complete regression of symptoms in the majority of patients, albeit with rather sketchy details and only clinical assessment of response in the early cases [7] . Data supporting objective tumor regression with radiation therapy are lacking. The optimal dose of radiation is not firmly established but it should be the minimal dose which will alleviate symptoms, given that this is the major goal of therapy. Most investigators report utilizing 20-30Gy (in 3-4 weeks) [7] . Given the relative radioresistance of normal vascular endothelium, the mechanism of radiation effect on this tumor is unknown. There is no evidence that radiation therapy relieves the coagulopathy present in patient with giant hepatic hemangiomas and Kassabach-Merritt syndrome. In the case presented here there was no improvement in any symptoms with low dose radiation treatment.
The role of arterial emoblization as a treatment for primary and secondary hepatic neoplasms is well established [8] . For hepatic hemangiomas and Kasabach-Merritt syndrome there are limited data, but one report utilizing intravenous cryoprecipitate plus infusion of intra-arterial thrombin and aminocaproic acid resulted in complete stasis within the hepatic hemangioma [9] . Unfortunately, in most cases, embolization is only temporarily effective in reducing the size of the hemangioma and improving the bleeding diathesis. As recanalization occurs, there is a concomitant recurrence of the coagulopathy [9, 10] . Thus, the drawbacks to embolization are recanalization and the possibility of a significant reduction in blood supply to an organ, resulting in ischemia and possibly infarction or necrosis.
While surgery appears to be the most effective treatment, whether giant cavernous hemangioma of the liver should be treated conservatively or removed is controversial. Even for symptomatic giant hemangiomas, some authors have advocated long-term follow up. One of the reasons given for this policy is that the morbidity and mortality rates associated with major liver resection have been suggested by some as prohibitive. The almost negligible mortality rate recently reported for elective resection in specialized centers does not support this view [4, [11] [12] [13] . Perioperative deaths generally occur during the rare case of emergent treatment of spontaneous bleeding or rupture [14] . Certainly, in those Patients presenting with hematologic decompensation, resection should be performed.
Case reports have described orthotopic liver transplantation for giant hemangioma of the liver and Kasabach-Merritt syndrome. In these two reports, hepatectomy was described as a difficult procedure because of the bulk and weight of the tumor. Blood loss was considerable in these reports with transfusion of 14 units of blood in one case and 17liters of blood products in the other [2, 3] . In one of the two cases, a reoperation was necessary due to hemorrhage. While operative mortality for liver transplantation has decreased considerably since its inception, operative mortality is still 10% and 5-year survival approximately 80% for benign disease [15] . In addition, patients must take lifelong medication with frequent follow up.
If surgical treatment is considered, we feel that surgical enucleation rather than liver transplantation is the procedure of choice for cavernous hepatic hemangiomas including those presenting with the Kasabach-Merritt syndrome. This is based on the assumption that coagulopathy and tumor size make it a technically difficult procedure whether enucleation or liver transplantation are performed. In specialized centers, enucleation should be associated with a mortality no higher than that for liver transplantation without the need for lifelong medication and follow up. The extensive blood supply of these lesions requires a meticulous and standardized approach. This has been described elsewhere and depends on prior control of the major extrahepatic feeding vessels, and dissection within the relatively less well perfused rim of compressed tissue through which the feeding vessels supply the lesion [4] . In one report, median blood loss with enucleation for 11 large hemangiomas was 800 ml. Even when the size of the tumor means that most of the right or left lobe has been removed, the disturbance of liver function is insignificant. The technique of enucleation allows safe removal of even very large lesions in most cases.
